Lipocine Inc. (LPCN) stock
LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3039% below fair value
$1.60−0.06 (-3.61%)
Close on Nov 17, 2026Market cap $13.19MP/E –Yield –
Lipocine total assets
Total assets on the balance sheet at the end of each period.
Lipocine's total assets was $23.84M at Jun 30, 2026. For fiscal 2025 it was $17.01M, down 24.5% from the year before. Over ten years it grew -9.3% a year on average. The highest annual figure on record is $52.48M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.01M | -24.5% |
| FY2024 | Dec 31, 2024 | $22.51M | -2.1% |
| FY2023 | Dec 31, 2023 | $23.00M | -38.7% |
| FY2022 | Dec 31, 2022 | $37.54M | -28.5% |
| FY2021 | Dec 31, 2021 | $52.48M | +107.0% |
| FY2020 | Dec 31, 2020 | $25.35M | +29.0% |
| FY2019 | Dec 31, 2019 | $19.66M | -5.7% |
| FY2018 | Dec 31, 2018 | $20.85M | -17.7% |
| FY2017 | Dec 31, 2017 | $25.33M | -7.4% |
| FY2016 | Dec 31, 2016 | $27.34M | -39.7% |
| FY2015 | Dec 31, 2015 | $45.38M | +62.1% |
| FY2014 | Dec 31, 2014 | $27.99M | -39.3% |
| FY2013 | Dec 31, 2013 | $46.11M | +728.3% |
| FY2012 | Dec 31, 2012 | $5.57M | +17056.9% |
| FY2011 | Dec 31, 2011 | $32.44K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.84M | +28.3% |
| Q1 FY2026 | Mar 31, 2026 | $25.36M | +23.7% |
| Q4 FY2025 | Dec 31, 2025 | $17.01M | -24.5% |
| Q3 FY2025 | Sep 30, 2025 | $16.07M | -22.3% |
| Q2 FY2025 | Jun 30, 2025 | $18.58M | -19.3% |
| Q1 FY2025 | Mar 31, 2025 | $20.50M | -19.4% |
| Q4 FY2024 | Dec 31, 2024 | $22.51M | -2.1% |
| Q3 FY2024 | Sep 30, 2024 | $20.70M | -16.4% |
| Q2 FY2024 | Jun 30, 2024 | $23.03M | -24.4% |
| Q1 FY2024 | Mar 31, 2024 | $25.45M | -25.2% |
| Q4 FY2023 | Dec 31, 2023 | $23.00M | -38.7% |
| Q3 FY2023 | Sep 30, 2023 | $24.75M | -37.2% |
| Q2 FY2023 | Jun 30, 2023 | $30.48M | -27.8% |
| Q1 FY2023 | Mar 31, 2023 | $34.02M | -28.5% |
| Q4 FY2022 | Dec 31, 2022 | $37.54M | -28.5% |
| Q3 FY2022 | Sep 30, 2022 | $39.42M | -2.4% |
| Q2 FY2022 | Jun 30, 2022 | $42.19M | -10.6% |
| Q1 FY2022 | Mar 31, 2022 | $47.60M | -5.9% |
| Q4 FY2021 | Dec 31, 2021 | $52.48M | +107.0% |
| Q3 FY2021 | Sep 30, 2021 | $40.39M | +63.2% |
| Q2 FY2021 | Jun 30, 2021 | $47.18M | +100.9% |
| Q1 FY2021 | Mar 31, 2021 | $50.58M | +140.9% |
| Q4 FY2020 | Dec 31, 2020 | $25.35M | +29.0% |
| Q3 FY2020 | Sep 30, 2020 | $24.75M | +42.7% |
| Q2 FY2020 | Jun 30, 2020 | $23.49M | +19.4% |
| Q1 FY2020 | Mar 31, 2020 | $20.99M | -8.7% |
| Q4 FY2019 | Dec 31, 2019 | $19.66M | -5.7% |
| Q3 FY2019 | Sep 30, 2019 | $17.34M | -23.6% |
| Q2 FY2019 | Jun 30, 2019 | $19.68M | -22.2% |
| Q1 FY2019 | Mar 31, 2019 | $22.99M | -27.4% |
| Q4 FY2018 | Dec 31, 2018 | $20.85M | -17.7% |
| Q3 FY2018 | Sep 30, 2018 | $22.69M | -13.6% |
| Q2 FY2018 | Jun 30, 2018 | $25.30M | -9.8% |
| Q1 FY2018 | Mar 31, 2018 | $31.68M | +16.4% |
| Q4 FY2017 | Dec 31, 2017 | $25.33M | -7.4% |
| Q3 FY2017 | Sep 30, 2017 | $26.26M | -11.2% |
| Q2 FY2017 | Jun 30, 2017 | $28.05M | – |
| Q1 FY2017 | Mar 31, 2017 | $27.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.34M | – |
| Q3 FY2016 | Sep 30, 2016 | $29.55M | – |
See a number that looks wrong?